Mumbai, Oct. 29 -- However, he will continue to be available with the company in terms of his contractual terms with the company and to facilitate seamless transition of his duties and responsibilities.

Further, the board of Cohance Lifesciences has approved the appointment of Himanshu Agarwal, presently designated as chief financial officer, as an additional director of the company, for a period of five years with effect from 29 October 2025.

The appointment of Himanshu Agarwal will be subject to approval of the shareholders of the company.

Himanshu Agarwal has been associated with the company as CFO from January 2, 2024. He started his professional career in 1991 and in his over 30 years of work experience has worked across multiple ...